共 10 条
[1]
Warren S(2005). Risks and benefits of activated protein C treatment for severe sepsis N Engl J Med 347 1027-1030
[2]
Suffredini AF(2005)Drotrecogin alfa (activated) for adults with severe sepsis and a low risk of death N Engl J Med 353 1332-1341
[3]
Eichacker PQ(2007)Drotrecogin alfa (activated) in children with severe sepsis: a multicentre phase III randomised controlled trial Lancet 369 836-843
[4]
Munford RS(undefined)undefined undefined undefined undefined-undefined
[5]
Abraham E(undefined)undefined undefined undefined undefined-undefined
[6]
Laterre F(undefined)undefined undefined undefined undefined-undefined
[7]
Garg R(undefined)undefined undefined undefined undefined-undefined
[8]
Nadel S(undefined)undefined undefined undefined undefined-undefined
[9]
Goldstein B(undefined)undefined undefined undefined undefined-undefined
[10]
Williams MD(undefined)undefined undefined undefined undefined-undefined